2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Jendryczko A and Tomala J | An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause. | 1993 | Zentralbl Gynakol | pmid:8503234 |
Oates JA et al. | Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man. | 1984 | Trans. Am. Clin. Climatol. Assoc. | pmid:6433527 |
Piret A et al. | Increased platelet aggregability and prostacyclin biosynthesis induced by intense physical exercise. | 1990 | Thromb. Res. | pmid:2140206 |
Reilly IA and FitzGerald GA | Eicosenoid biosynthesis and platelet function with advancing age. | 1986 | Thromb. Res. | pmid:3754355 |
Vesterqvist O et al. | Thromboxane and prostacyclin formation in patients with deep vein thrombosis. | 1987 | Thromb. Res. | pmid:3554598 |
Vericel E et al. | Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. | 1988 | Thromb. Res. | pmid:3129819 |
Kudolo GB et al. | Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. | 2002 | Thromb. Res. | pmid:12590952 |
Saloheimo P et al. | Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. | 2005 | Thromb. Res. | pmid:15733969 |
Morio H et al. | Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects. | 1993 | Thromb. Haemost. | pmid:8470052 |
Tohgi H et al. | Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. | 1992 | Stroke | pmid:1412574 |
Numminen H et al. | The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. | 2000 | Stroke | pmid:10835443 |
Vesterqvist O et al. | In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. | 1988 | Scand. J. Clin. Lab. Invest. | pmid:3375779 |
Tanaka H et al. | Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients? | 1999 | Respir Med | pmid:10653051 |
Vesterqvist O et al. | Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans. | 1987 | Res Exp Med (Berl) | pmid:3303204 |
Rosenkranz B et al. | Urinary and systemic metabolites of prostacyclin in the perfused rabbit kidney. | 1982 | Ren Physiol | pmid:6750728 |
Mizugaki M et al. | Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593167 |
Hishinuma T et al. | Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593168 |
Hoch B and Bernhard M | Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593170 |
Blatnik M and Steenwyk RC | Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS/MS before and after exercise. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20416393 |
Lynch CM et al. | The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. | 2011 | Prostaglandins Other Lipid Mediat. | pmid:21723954 |